Joel Edwards

Raina is at the forefront of generative AI for mRNA therapeutic design. Powered by its proprietary GEMORNA platform, the company is breaking new ground in mRNA engineering, generating sequences with markedly enhanced translational efficiency, stability, and potency — results recently featured in Science.
Raina’s AI engine explores expansive, multi-dimensional sequence space, incorporating latent representations of mRNA features to identify superior designs. This enables zero-shot optimization with high success rates, shortening preclinical timelines and advancing programs with unmatched speed and accuracy.
Raina’s integrated lab capabilities provide a true closed-loop design platform, enabling rapid synthesis and high-throughput screening of AI-designed sequences. This parallelized design-test cycle accelerates the discovery of potent, durable mRNA therapeutics, empowering partners to move forward with confidence.

Raina Biosciences